Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Anticipated CAGR of the Artificial Intelligence (AI) In Biopharmaceuticals Market, and What Factors Will Drive It?
The market size of artificial intelligence (AI) in biopharmaceuticals has experienced a tremendous increase recently. The projection is that it will rise from $1.59 billion in 2024 to $2.1 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 32.2%. The substantial expansion during the historical period can be linked to developments in computational capabilities, the surge of biomedical data, paradigm of precision medicine, as well as regulatory assistance and direction.
The market size for artificial intelligence (AI) in biopharmaceuticals is projected to witness a substantial increase in the forthcoming years, reaching $6.58 billion by 2029 with a compound annual growth rate (CAGR) of 33.0%. The expected expansion during the forecast period can be credited to advancements in computational biology, the harmonizing of multi-modal data, the meeting point of ai and life sciences, supportive regulatory frameworks, and just and ethical ai principles. Major trends anticipated during the forecast span include the unification of multi-omics data, drug design, and discovery driven by AI, understandable AI and regulatory approval, advancements in technology, evolutions in regulations, and burgeoning opportunities.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14251&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Artificial Intelligence (AI) In Biopharmaceuticals Market?
The escalating incidence of chronic diseases is anticipated to spur the expansion of the artificial intelligence (AI) in biopharmaceuticals market in the future. These long-term conditions progress at a slow rate and can endure for many years or even a person’s entire lifespan. They occur due to factors such as lifestyle choices, an aging populace, genetic tendencies, and environmental conditions. AI in biopharmaceuticals is now being increasingly employed to handle these chronic conditions as it can process large quantities of diverse data, detect patterns and customize treatment methods. For example, the Department of Health and Human Services reported in November 2023 that there was an 11 percent rise in new cases of chronic hepatitis B in the United States in 2022 compared to 2021. Consequently, the accelerating prevalence of chronic diseases is fueling the growth of the AI sector in the biopharmaceuticals market.
Which Key Market Segments Comprise the Artificial Intelligence (AI) In Biopharmaceuticals Market and Drive Its Revenue Growth?
The artificial intelligence (ai) in biopharmaceuticals market covered in this report is segmented –
1) By Offering: Hardware, Software, Services
2) By Deployment: Cloud, On-Premises
3) By Technology: Machine Learning, Natural Language Processing, Deep Learning, Other Technologies
4) By Application: Business Process And Supply Chain, Drug Discovery, Medical Imaging And Diagnostics, Precision Medicine
5) By End-Users: Manufacturers, Contract Research Organizations, Academic And Government Research Institutes
Subsegments:
1) By Hardware: High-Performance Computing Systems, AI-Enabled Laboratory Equipment, Data Storage Solutions
2) By Software: Drug Discovery Platforms, Clinical Trial Management Software, Predictive Analytics Tools, Natural Language Processing Solutions
3) By Services: Consulting Services, Implementation And Integration Services, Data Management And Analytics Services, Training And Support Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=14251&type=smp
Which Areas Are Leading Regions in the Artificial Intelligence (AI) In Biopharmaceuticals Market Expansion Across the Globe?
North America was the largest region in the artificial intelligence (AI) in biopharmaceuticals market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) in biopharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in theArtificial Intelligence (AI) In Biopharmaceuticals Market Over the Coming Years?
Top-tier firms involved in the field of AI within biopharmaceuticals are prioritizing the creation of revolutionary improvements such as the target and lead identification suite AI-driven systems. These systems are aimed at speeding up the discovery of drugs and precision medicine, essentially changing the game within the field of life sciences. These tech-enabled improvements for the rapid discovery of drugs and precision medicine have a wide range of unique techniques for creating new drugs and personalizing therapy for patients. For example, Google LLC, an American-based cloud computing service provider, rolled out two new AI-driven tools – target and lead identification suites – in May 2023. These tools are meant to aid researchers in fortelling and comprehending protein structures, a vital aspect of drug creation. Additionally, this suite will assist researchers in absorbing, retaining, scrutinizing, and sharing vast amounts of genomic data, which is key to precision medicine. Moreover, these instruments aspire to simplify the drug discovery process, lessen expenses, and hasten the availability of new treatments in the market. By offering efficient data management, precise projections of protein structures, and superior genomic analysis capabilities, these tools hope to revolutionize drug development procedures and enhance patient outcomes.
View the full report here:
How Is the Artificial Intelligence (AI) In Biopharmaceuticals Market Conceptually Defined?
Artificial intelligence (AI) in biopharmaceuticals refers to applying various AI techniques to analyze complex biological data and improve various aspects of drug discovery, development, and delivery within the pharmaceutical industry. AI in biopharmaceuticals holds great promise for revolutionizing drug discovery, development, and delivery processes by accelerating timelines, reducing costs, and improving the efficiency and effectiveness of treatments.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14251
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model